Literature DB >> 833658

Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties.

H L Atkins, T F Budinger, E Lebowitz, A N Ansari, M W Greene, R G Fairchild, K J Ellis.   

Abstract

Studies were undertaken to determine the biologic distribution of thallium-201 in man. The disappearance from the blood is extremely rapid and intracellular deposition is nearly immediate. The biologic half-time of thallium was measured by both the Brookhaven whole-body counter and the Donner whole-body scanner, with excellent agreement. The effective whole-body half-time of thallium-201 is about 57 hr. Concentration of activity was seen in the heart, kidneys, large bowel, and thyroid. The whole-body radiation dose is 0.21 rads/mCi.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 833658

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  34 in total

1.  Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities.

Authors:  Gregory P Sanders; Duane S Pinto; J Anthony Parker; Polyxeni Koutkia; Franz C Aepfelbacher; Peter G Danias
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

Authors:  M Ricci; P Pantano; A Pierallini; D Di Stefano; A Santoro; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Tl-201 stress tests and homeland security.

Authors:  Lawrence T Dauer; Matthew J Williamson; Jean St Germain; H William Strauss
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

Review 4.  Quantitative assessment of regional myocardial blood flow with thallium-201 and SPECT.

Authors:  H Iida; S Eberl
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

5.  Effects of physical stress and pharmacologically induced coronary dilation on myocardial and non-myocardial 201Thallium-uptake.

Authors:  U Büll; B E Strauer; S Bürger; J Witte; H P Niendorf
Journal:  Eur J Nucl Med       Date:  1978

6.  Finding sensitive parameters in internal dose calculations for radiopharmaceuticals commonly used in clinical nuclear medicine.

Authors:  Vladimir Spielmann; Wei Bo Li; Maria Zankl
Journal:  Radiat Environ Biophys       Date:  2018-06-29       Impact factor: 1.925

7.  Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.

Authors:  J C Maublant; N Moins; P Gachon
Journal:  Eur J Nucl Med       Date:  1989

8.  Scintigraphic evaluation and dynamic studies with thallium-201 in thyroid lesions with suspected cancer.

Authors:  J Tennvall; J Palmer; E Cederquist; I Larsson; A Biörklund; S Ingemansson; M Akerman
Journal:  Eur J Nucl Med       Date:  1981

9.  A new method with high sensitivity and specificity for localization of abnormal parathyroid glands.

Authors:  M D Okerlund; K Sheldon; S Corpuz; W O'Connell; D Faulkner; O Clark; M Galante
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

10.  The (F)utility of the thallium-201 quantitative lung/myocardial ratio in the detection of coronary artery disease.

Authors:  R L Wahl; B Kumar; D R Biello; T R Miller
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.